Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

Shuji Momose1, Jun-ichi Tamaru, Hirohisa Kishi

  • 1Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama 350-8550, Japan. momose@saitama-med.ac.jp

Human Pathology
|August 30, 2008
PubMed
Summary

Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma (DLBCL) with clathrin-ALK fusion shows activated STAT3 signaling. This rare cancer subtype exhibits distinct STAT protein profiles compared to ALK-negative DLBCL.